2nd Quarter - Report

JIM SAXTON, LLC for EMERGENT BIOSOLUTIONS

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Homeland Security HOM

All provisions relating to development, acquisition and stockpiling of biodefense vaccines: Dept of Homeland Security Appropriations Act FY 2012; HR 2017 Department of Labor, Health & Human Services & Education Act 2012; HR 2356 WMD Prevention and Preparedness Act 2011;

LobbyistCovered position, as disclosed
MICHAEL STEPHAN HOPKINS —
JIM SAXTON —

Bills named: H.R. 2017 (112th), H.R. 2356 (112th)

Defense DEF

Anthrax vaccine & immunoglobulin research, acquisition, immunization, legislation, funding, appropriations and oversight.

LobbyistCovered position, as disclosed
MICHAEL STEPHAN HOPKINS —
JIM SAXTON —

Disaster Planning/Emergencies DIS

All provisions relating to development, acquisition and stockpiling of biodefense vaccines: Dept of Homeland Security Appropriations Act FY 2012; HR 2017 Department of Labor, Health & Human Services & Education Act 2012; HR 2356 WMD Prevention and Preparedness Act 2011;

LobbyistCovered position, as disclosed
MICHAEL STEPHAN HOPKINS —
JIM SAXTON —

Bills named: H.R. 2356 (112th), H.R. 2017 (112th)

Health Issues HCR

All provisions relating to development, acquisition and stockpiling of biodefense vaccines: Dept of Homeland Security Appropriations Act FY 2012; HR 2017 Department of Labor, Health & Human Services & Education Act 2012; HR 2356 WMD Prevention and Preparedness Act 2011;

LobbyistCovered position, as disclosed
MICHAEL STEPHAN HOPKINS —
JIM SAXTON —

Bills named: H.R. 2017 (112th), H.R. 2356 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.